Creative Medical Technology Holdings, Inc. (CELZ)
NASDAQ: CELZ · Real-Time Price · USD
2.170
+0.030 (1.40%)
At close: Apr 13, 2026, 4:00 PM EDT
2.220
+0.050 (2.30%)
After-hours: Apr 13, 2026, 7:57 PM EDT
CELZ Employees
Creative Medical Technology Holdings had 4 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
4
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$1,500
Profits / Employee
-$1,498,752
Market Cap
8.02M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 4 | 0 | - |
| Dec 31, 2024 | 4 | 0 | - |
| Dec 31, 2023 | 4 | 0 | - |
| Dec 31, 2022 | 4 | 0 | - |
| Dec 31, 2021 | 4 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Evogene | 117 |
| BioAtla | 41 |
| Quince Therapeutics | 36 |
| NuCana | 12 |
| Processa Pharmaceuticals | 12 |
| MetaVia | 8 |
| TransCode Therapeutics | 7 |
| Acurx Pharmaceuticals | 4 |
CELZ News
- 3 months ago - Creative Medical Technology Holdings Reaches Major Clinical Inflection Point with Positive Interim Data from ADAPT Trial and CELZ-201 (Olastrocel) in the Treatment of Chronic Lower Back Pain - GlobeNewsWire
- 3 months ago - Creative Medical Technology Holdings Receives Regulatory Approval for BioDefense Burn Pit Initiative - GlobeNewsWire
- 4 months ago - Creative Medical Technology Holdings, Inc. Completes Enrollment in FDA-Cleared ADAPT Trial for CELZ-201-Olastrocel, Marking Major Clinical Inflection Point - GlobeNewsWire
- 4 months ago - Creative Medical Technology Holdings Announces World Health Organization Approval of “olastrocel” as INN for Lead Allogeneic Cell Therapy CELZ-201 - GlobeNewsWire
- 5 months ago - Creative Medical Technology Holdings, Inc. Ignites Next-Gen Regenerative BioDefense Initiative for U.S. Veterans Exposed to Burn Pits - GlobeNewsWire
- 5 months ago - Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $4.2 Million Gross Proceeds - GlobeNewsWire
- 6 months ago - Creative Medical Technology Holdings Issues Letter to Shareholders - GlobeNewsWire
- 6 months ago - Creative Medical Technology Holdings Congratulates 2025 Nobel Laureates for Regulatory T Cell Breakthroughs - GlobeNewsWire